Location: New York, NY
CIK: 0001534261 · Show all filings
Period: Q4 2020 (← Previous) (Next →)
Filing Date: Feb 16, 2021
Total Value: $3.375B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | INVITAE CORP | 12,298,038 | $514M | 15.2% | $2864.61 | — | COM | 46185L103 |
| BLFS | BIOLIFE SOLUTIONS INC | 7,440,107 | $297M | 8.8% | $19.73 | +72.8% | COM NEW | 09062W204 |
| FATE | FATE THERAPEUTICS INC | 3,050,000 | $277M | 8.2% | $8.50 | +630.2% | COM | 31189P102 |
| EXAS | EXACT SCIENCES CORP | 1,485,149 | $197M | 5.8% | $120.93 | 0.0% | COM | 30063P105 |
| — | BLUEPRINT MEDICINES CORP | 1,550,000 | $174M | 5.1% | $5615.52 | — | COM | 09627Y109 |
| RLAY | RELAY THERAPEUTICS INC | 3,808,894 | $158M | 4.7% | $38.13 | +18.6% | COM | 75943R102 |
| TWST | TWIST BIOSCIENCE CORP | 1,000,000 | $141M | 4.2% | $26.75 | +314.7% | COM | 90184D100 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 5,000,000 | $130M | 3.8% | $6.88 | +147.0% | COM | 69404D108 |
| DNLI | DENALI THERAPEUTICS INC | 1,310,000 | $110M | 3.3% | $18.95 | +219.0% | COM | 24823R105 |
| AGIO | AGIOS PHARMACEUTICALS INC | 2,375,000 | $103M | 3.0% | $45.91 | -13.9% | COM | 00847X104 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 780,000 | $101M | 3.0% | $100.40 | +33.0% | COM | 02043Q107 |
| CDXS | CODEXIS INC | 4,330,000 | $94.52M | 2.8% | $14.14 | +16.4% | COM | 192005106 |
| SRPT | SAREPTA THERAPEUTICS INC | 530,000 | $90.36M | 2.7% | $121.78 | +21.7% | COM | 803607100 |
| CDNA | CAREDX INC | 1,193,335 | $86.46M | 2.6% | $24.07 | +140.8% | COM | 14167L103 |
| RVMD | REVOLUTION MEDICINES INC | 1,634,535 | $64.71M | 1.9% | $27.72 | +42.6% | COM | 76155X100 |
| — | CONSTELLATION PHARMCETICLS I | 1,785,000 | $51.41M | 1.5% | $16.45 | — | COM | 210373106 |
| — | GENERATION BIO CO | 1,611,214 | $45.68M | 1.4% | $21.00 | — | COM | 37148K100 |
| DMTKQ | DERMTECH INC | 1,370,000 | $44.44M | 1.3% | $11.88 | — | COM | 24984K105 |
| — | BURNING ROCK BIOTECH LTD | 1,922,150 | $44.4M | 1.3% | $26.82 | — | SPONSORED ADS | 12233L107 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | 713,125 | $42.17M | 1.2% | $37.47 | +37.6% | COM | 00650F109 |
| CRSP | CRISPR THERAPEUTICS AG | 266,430 | $40.79M | 1.2% | $51.63 | +128.9% | NAMEN AKT | H17182108 |
| — | BLUEBIRD BIO INC | 915,000 | $39.59M | 1.2% | $21744.46 | — | COM | 09609G100 |
| — | ADVERUM BIOTECHNOLOGIES INC | 3,650,000 | $39.57M | 1.2% | $12.41 | — | COM | 00773U108 |
| ONC | BEIGENE LTD | 150,000 | $38.76M | 1.1% | $188.40 | — | SPONSORED ADR | 07725L102 |
| BEAM | BEAM THERAPEUTICS INC | 460,000 | $37.55M | 1.1% | $49.18 | 0.0% | COM | 07373V105 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 810,000 | $35.08M | 1.0% | $40.67 | — | COM | 37890U108 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 780,555 | $32.35M | 1.0% | $41.28 | 0.0% | COM | 35104E100 |
| — | MAGENTA THERAPEUTICS INC | 3,346,034 | $26.23M | 0.8% | $1663.66 | — | COM | 55910K108 |
| ZLAB | ZAI LAB LTD | 190,000 | $25.71M | 0.8% | $51.48 | — | ADR | 98887Q104 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 550,000 | $25.52M | 0.8% | $34.93 | +13.7% | COM | 462260100 |
| ALEC | ALECTOR INC | 1,650,000 | $24.96M | 0.7% | $17.70 | -29.8% | COM | 014442107 |
| ALLO | ALLOGENE THERAPEUTICS INC | 945,000 | $23.85M | 0.7% | $30.15 | +8.1% | COM | 019770106 |
| MASS | 908 DEVICES INC | 406,502 | $23.15M | 0.7% | $58.41 | 0.0% | COM | 65443P102 |
| TSHA | TAYSHA GENE THERAPIES INC | 820,440 | $21.77M | 0.6% | $23.52 | -8.4% | COM SHS | 877619106 |
| ORIC | ORIC PHARMACEUTICALS INC | 601,515 | $20.36M | 0.6% | $30.04 | -4.5% | COM | 68622P109 |
| — | BERKELEY LTS INC | 200,000 | $17.88M | 0.5% | $76.36 | — | COM | 084310101 |
| — | KRONOS BIO INC | 583,436 | $17.43M | 0.5% | $29.87 | — | COM | 50107A104 |
| SGMO | SANGAMO THERAPEUTICS INC | 1,080,000 | $16.85M | 0.5% | $8.80 | +33.2% | COM | 800677106 |
| FULC | FULCRUM THERAPEUTICS INC | 1,241,176 | $14.53M | 0.4% | $11.41 | -1.0% | COM | 359616109 |
| — | AMYRIS INC | 2,000,000 | $12.35M | 0.4% | $3.90 | — | Call | 03236M200 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 450,000 | $10.01M | 0.3% | $20.74 | 0.0% | COM | 87164F105 |
| BDTX | BLACK DIAMOND THERAPEUTICS I | 289,395 | $9.275M | 0.3% | $30.22 | +8.7% | COM | 09203E105 |
| — | TURNING POINT THERAPEUTICS I | 75,000 | $9.139M | 0.3% | $40080.00 | — | COM | 90041T108 |
| SEER | SEER INC | 150,000 | $8.421M | 0.2% | $63.62 | 0.0% | COM CL A | 81578P106 |
| ABCL | ABCELLERA BIOLOGICS INC | 200,000 | $8.048M | 0.2% | $45.73 | 0.0% | COM | 00288U106 |
| DYN | DYNE THERAPEUTICS INC | 370,000 | $7.77M | 0.2% | $21.96 | -9.9% | COM | 26818M108 |
| STOK | STOKE THERAPEUTICS INC | 120,000 | $7.432M | 0.2% | $27.21 | +68.5% | COM | 86150R107 |
| FHTX | FOGHORN THERAPEUTICS INC | 216,216 | $4.383M | 0.1% | $19.16 | 0.0% | COM | 344174107 |
| — | BRISTOL-MYERS SQUIBB CO | 6,250,000 | $4.313M | 0.1% | $2.78 | — | RIGHT 99/99/9999 | 110122157 |
| — | CODIAK BIOSCIENCES INC | 76,688 | $2.477M | 0.1% | $32.30 | — | COM | 192010106 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 50,000 | $2.166M | 0.1% | $40.67 | — | Call | 37890U108 |
| CCCC | C4 THERAPEUTICS INC | 40,000 | $1.325M | 0.0% | $29.00 | 0.0% | COM STK | 12529R107 |